Koyfin Home > Directory > Health Care > Acorda Therapeutics > Net Income Margin

Acorda Therapeutics Net Income Margin Chart (ACOR)

Acorda Therapeutics annual/quarterly Net Income Margin from 2010 to 2020. Net profit margin, or net margin, is equal to net income or profits divided by total revenue and represents how much profit each dollar of sales generates. Net profit margin is the ratio of net profits or net income to revenues for a company.
  • Acorda Therapeutics Net Income Margin for the quarter ending June 06, 2020 was $-52m a -965.66% increase of 500m year over year
  • Acorda Therapeutics Net Income Margin for the last 12 months ending June 06, 2020 was $-139m a -12.43% increase of 17m year over year
  • Acorda Therapeutics Annual Net Income Margin for 2019 was $-142m a 105.04% decrease of -149m from 2018
  • Acorda Therapeutics Annual Net Income Margin for 2018 was $7m a 631.42% increase of 45m from 2017
  • Acorda Therapeutics Annual Net Income Margin for 2017 was $-38m a 82.45% decrease of -31m from 2016
Other Margins & Efficiency Metrics:
  • Acorda Therapeutics EBITDA Margin for the quarter ending December 12, 2018 was $-20m a 159.12% decrease of -32m year over year
  • Acorda Therapeutics Return on Capital % for the quarter ending December 12, 2018 was -4.27 a 144.67% decrease of -6.18 year over year
  • Acorda Therapeutics Return on Equity % for the quarter ending December 12, 2018 was 6.34 a 196.69% increase of 12.47 year over year
View Chart On Koyfin

Quarterly ACOR Net Income Margin Data

06/2020$-52m
03/2020$-23m
12/2019$130m
09/2019$-552m
06/2019$-55m
03/2019$-108m
12/2018$14m
09/2018$-10m
06/2018$30m
03/2018$-8m

Annual ACOR Net Income Margin Data

2019$-142m
2018$7m
2017$-38m
2016$-7m
2015$2m
2014$4m
2013$5m
2012$51m
2011$10m
2010$-6m